PubMed Health⌕ Search

Biomedical subjects

Daniel T Lee

Publications and source records attributed to Daniel T Lee.

3 recordsLinked to original sources

Patterns of coronary compromise leading to bradyarrhythmias and hypotension in inferior myocardial infarction.

BACKGROUND: Occlusion and reperfusion of the acutely occluded right coronary artery may result in abrupt bradycardia and hypotension, attributed to Bezold-Jarisch cardio-inhibitory reflexes arising from the ischemic left ventricle. Given that right ventricular infarction, a result of proximal right coronary artery occlusion, predisposes to bradycardia and hypotension, we hypothesized that proximal right coronary occlusions would be more likely to result in bradycardia-hypotension compared to more distal occlusions. METHODS: In 216 patients with acute inferior myocardial infarction undergoing primary angioplasty of the right coronary artery, we retrospectively analyzed the incidence of bradyarrhythmias and hypotension during occlusion and with reperfusion. RESULTS: Occlusion proximal to the right ventricular branches was identified in 151 (70%) of cases, with occlusions distal but compromising the left ventricular and atrioventricular nodal branches in 65 (30%) others. During occlusion, those with proximal occlusions were more likely to suffer hypotension (41 versus 15%, P=0.0002), advanced atrioventricular block (21 versus 3%, P=0.0008) and hypotension with bradycardia (25 versus 9%, P=0.01). Similarly, reperfusion of proximal occlusions more frequently resulted in abrupt hypotension (42 versus 19%, P=0.002), bradycardia (34 versus 14%, P=0.004) and hypotension with bradycardia (27 versus 12%, P=0.02). CONCLUSIONS: These data demonstrate that during right coronary artery occlusion and with reperfusion, bradycardia and hypotension develop more commonly in patients with proximal occlusions compared with those with distal occlusions. These findings suggest that reflexes arising from the ischemic right ventricle may play a role in bradyarrhythmias and hypotension.

Bradycardia↗

Hypertriglyceridemia.

Hypertriglyceridemia is a commonly encountered lipid abnormality frequently associated with other lipid and metabolic derangements. The National Cholesterol Education Program recommends obtaining a fasting lipid panel in adults over the age of 20. The discovery of hypertriglyceridemia should prompt an investigation for secondary causes such as high fat diet, excessive alcohol intake, certain medications, and medical conditions (eg, diabetes mellitus, hypothyroidism). In addition, patients should be evaluated for other components of the metabolic syndrome. These include abdominal obesity, insulin resistance, low high-density lipoprotein (HDL), high triglyceride, and hypertension. Hypertriglyceridemia is classified as primary hypertriglyceridemia when there are no secondary causes identified. Primary hypertriglyceridemia is the result of various genetic defects leading to disordered triglyceride metabolism. It is important to treat hypertriglyceridemia to prevent pancreatitis by reducing triglyceride levels to <500 mg/dL. Furthermore, lowering triglycerides while treating other dyslipidemias and components of the metabolic syndrome will reduce coronary events. However, it is controversial how much isolated hypertriglyceridemia correlates directly with coronary artery disease and further studies are needed to clarify whether treatment for this condition leads to meaningful clinical outcomes. Therapeutic lifestyle changes (TLC) are the first line of treatment for hypertriglyceridemia. These changes include a low saturated fat, carbohydrate-controlled diet, combined with alcohol reduction, smoking cessation, and regular aerobic exercise. High doses of omega-3 fatty acids from fish and fish oil supplements will lower triglyceride levels significantly. When patients do not reach their goals by TLC, drug therapy should be started. In cases of isolated hypertriglyceridemia, fibrates are initially considered. When elevated low-density lipoprotein levels accompany hypertriglyceridemia, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors are preferred. In patients with low HDL levels and hypertriglyceridemia, extended release niacin can be considered. A combination of the medicines may be necessary in recalcitrant cases.

Adult↗